Suppr超能文献

[所有人工瓣膜患者都应该接受抗血小板药物治疗吗?]

[Should all prosthetic valve patients be treated by platelet inhibitors?].

作者信息

Lévy G, Bordes F, Mariottini P, François G

出版信息

Nouv Presse Med. 1976 Jan 31;5(5):251-4.

PMID:1264682
Abstract

The number, volume and adhesive and aggregation activities of platelets were studied in 31 patients with artificial valves. The differences observed in comparison with a control population are due to stimulation of thrombocytopoiesis secondary to the destruction or concumption of the platelets, it being impossible to be sure as to the dominant mechanism. Under these circumstances it would seem important in each patient to verify the therapeutic effectiveness of platelet inhibitors or of traditionnal anticoagulants by direct or indirect study of platelet life duration.

摘要

对31例人工瓣膜患者的血小板数量、体积以及黏附与聚集活性进行了研究。与对照组相比所观察到的差异是由于血小板破坏或消耗继发的血小板生成刺激所致,目前尚无法确定主要机制。在这种情况下,通过直接或间接研究血小板寿命来验证血小板抑制剂或传统抗凝剂对每位患者的治疗效果似乎很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验